1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Claritas Pharmaceuticals Acquires Salzman Group

M&A Deal Summary

Claritas Pharmaceuticals Acquires Salzman Group

On May 19, 2020, Claritas Pharmaceuticals acquired life science company Salzman Group

Acquisition Highlights
  • This is Claritas Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Claritas Pharmaceuticals’ 1st transaction in the United States.
  • This is Claritas Pharmaceuticals’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2020-05-19
Target Salzman Group
Sector Life Science
Buyer(s) Claritas Pharmaceuticals
Deal Type Add-on Acquisition

Target

Salzman Group

West Tisbury, Massachusetts, United States
Salzman Group, Inc. is a global drug development company that seeks to transform medical practice by undertaking transformative pharmaceutical innovation. As an organization, Salzman Group prides itself on a high-energy culture of accountability, teamwork, and creativity. Salzman Group was formed in 1996 and is based in West Tisbury, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Claritas Pharmaceuticals

San Rafael, Massachusetts, United States
Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Claritas Pharmaceuticals is a developer of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. Claritas Pharmaceuticals was founded in 2014 and is headquartered in San Rafael, California.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-16 Talent Biotechs

Bnei Brak, Israel

Talent Biotechs Ltd. is an Israeli-based company evaluating the use of CBD to prevent and treat Graft versus Host Disease (“GvHD”).

Buy $10M
Mergr

Solution for

Product

Company

Legal